Tocolysis for acute preterm labor: does anything work

References

• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84
   PubMed Web of Science ®Google Scholar
• Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002;360:1489–97
   PubMed Web of Science ®Google Scholar
• Hollier LM. Preventing preterm birth: what works, what doesn't. Obstet Gynecol Surv 2005;60:124–31
   PubMed Web of Science ®Google Scholar
• Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2010. Nastl Vital Stat Rep 2011;60:1–26
   PubMedGoogle Scholar
• Shennan AH, Bewley S. Why should preterm births be rising? BMJ 2006;332:924–5
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Kusanovich J, et al. The preterm parturition syndrome. BJOG 2006;113:17–85
   PubMed Web of Science ®Google Scholar
• Katz VL, Farmer RM. Controversies in tocolytic therapy. Clin Obstet Gynecol 1999;42:802–19
   PubMed Web of Science ®Google Scholar
• Ward RM, Beachy JC. Neonatal complications following preterm birth. BJOG 2003;110:8–16
   PubMed Web of Science ®Google Scholar
• McParland PC. Obstetric management of moderate and late preterm labour. Semin Fetal Neonatal Med 2012;17:138–42
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. Tocolytioc drugs for women in preterm labour. Green-top 1b; 2011. Available from: http://www.guideline.gov/content.aspx?id=25674 [last accessed 22 Feb 2011]
   Google Scholar
• Meloni A, Melis M, Alba E, et al. Medical therapy in the management of preterm birth. J Matern Fetal Neonatal Med 2009;22:72–6
   PubMed Web of Science ®Google Scholar
• Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med 2007;357:477–87
   PubMed Web of Science ®Google Scholar
• Groom KM. Preterm labour. Pharmacological prevention of prematurity. Best Pract Res Clin Obstet Gynaecol 2007;21:843–56
   PubMedGoogle Scholar
• Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol 1964;24:266–8
   PubMed Web of Science ®Google Scholar
• Houlton MC, Marivate M, Philpott RH. Factors associated with preterm labour and changes in the cervix before labour in twin pregnancy. Br J Obstet Gynaecol 1982;89:190–4
   PubMedGoogle Scholar
• Newman RB, Goldenberg RL, Iams JD, et al. Preterm prediction study: comparison of the cervical score and Bishop score for prediction of spontaneous preterm delivery. Obstet Gynecol 2008;112:508–15
   PubMed Web of Science ®Google Scholar
• Fonseca EB, Celik E, Parra M, et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462–9
   PubMed Web of Science ®Google Scholar
• Mella MT, Berghella V. Prediction of preterm birth: cervical sonography. Semin Perinatol 2009;33:317–24
   PubMed Web of Science ®Google Scholar
• Guzman ER, Walters C, Ananth CV, et al. A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton gestations. Ultrasound Obstet Gynecol 2001;18:204–10
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Roura LC. Guidelines for the management of spontaneous preterm labor. J Perinat Med 2006;34:359–66
   PubMed Web of Science ®Google Scholar
• Berkman ND, Thorp Jr JM, Lohr KN, et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol 2003;188:1648–59
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol 2011;204:134–20
   PubMedGoogle Scholar
• Wex J, Connolly M, Rath W. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation. BMC Pregnancy Childbirth 2009;9:23
   PubMed Web of Science ®Google Scholar
• Hubinont C, Debieve F. Prevention of preterm labour: 2011 update on tocolysis. J Pregnancy 2011;2011:941057
   PubMedGoogle Scholar
• Gyetvai K, Hannah ME, Hodnett ED, et al. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999;94:869–77
   PubMed Web of Science ®Google Scholar
• Neilson JP. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Obstet Gynecol 2007;109:189–90
   PubMed Web of Science ®Google Scholar
• Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;(3):CD004454
   PubMed Web of Science ®Google Scholar
• Baumbach J, Shi SQ, Shi L, et al. Inhibition of uterine contractility with various tocolytics with and without progesterone: in vitro studies. Am J Obstet Gynecol 2012;206:254–5
   PubMedGoogle Scholar
• de Heus R, Mol BW, Erwich JJ, et al. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ 2009;338:b744
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Al SE, Mattei A, et al. Use of tocolytics: what is the benefit of gaining 48 hours for the fetus? BJOG 2006;113:72–7
   PubMed Web of Science ®Google Scholar
• Haas DM, Imperiale TF, Kirkpatrick PR, et al. Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol 2009;113:585–94
   PubMed Web of Science ®Google Scholar
• Haram K, Mortensen JH, Wollen AL. Preterm delivery: an overview. Acta Obstet Gynecol Scand 2003;82:687–704
   PubMed Web of Science ®Google Scholar
• Lamont RF, Dunlop PD, Crowley P, et al. Comparative mortality and morbidity of infants transferred in utero or postnatally. J Perinat Med 1983;11:200–3
   PubMed Web of Science ®Google Scholar
• Blumenfeld YJ, Lyell DJ. Prematurity prevention: the role of acute tocolysis. Curr Opin Obstet Gynecol 2009;21:136–41
   PubMedGoogle Scholar
• Anotayanonth S, Subhedar NV, Garner P, et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004;(4):CD004352
   PubMedGoogle Scholar
• Mizuki J, Tasaka K, Masumoto N, et al. Magnesium sulfate inhibits oxytocin-induced calcium mobilization in human puerperal myometrial cells: possible involvement of intracellular free magnesium concentration. Am J Obstet Gynecol 1993;169:134–9
   PubMedGoogle Scholar
• Crowther CA, Hiller JE, Doyle LW. Magnesium sulfate for preventing preterm birth in threatening preterm labor. Cochrane Database Syst Rev 2002;(4):CD001060
   Google Scholar
• Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 2006;108:986–9
   PubMed Web of Science ®Google Scholar
• Scudiero R, Khoshnood B, Pryde PG, et al. Perinatal death and tocolytic magnesium sulfate. Obstet Gynecol 2000;96:178–82
   PubMed Web of Science ®Google Scholar
• Elliott JP, Lewis DF, Morrison JC, et al. In defense of magnesium sulfate. Obstet Gynecol 2009;113:1341–8
   PubMed Web of Science ®Google Scholar
• Lewis DF. Magnesium sulfate: the first-line tocolytic. Obstet Gynecol Clin North Am 2005;32:485–500
   PubMed Web of Science ®Google Scholar
• Elliott JP, Garite TJ, Clark R, et al. Perinatal effect of magnesium sulfate administered for tocolysis. Am J Obstet Gynecol 2003;189:563
   Google Scholar
• Committee Opinion No. 573: Magnesium sulfate use in obstetrics. Obstet Gynecol 2013;122:727–8
   Google Scholar
• Costantine MM, Weiner SJ. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol 2009;114:354–64
   PubMed Web of Science ®Google Scholar
• Reeves SA, Gibbs RS, Clark SL. Magnesium for fetal neuroprotection. Am J Obstet Gynecol 2011;204:202–4
   PubMedGoogle Scholar
• Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009;(1):CD004661
   PubMed Web of Science ®Google Scholar
• Abdul MA, Nasir UI, Khan N, et al. Low-dose magnesium sulphate in the control of eclamptic fits: a randomized controlled trial. Arch Gynecol Obstet 2013;287:43–6
   PubMedGoogle Scholar
• Gilbert WM. The cost of preterm birth: the low cost versus high value of tocolysis. BJOG 2006;113:4–9
   PubMedGoogle Scholar
• Coomarasamy A, Knox EM, Gee H, et al. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials. BJOG 2003;110:1045–9
   PubMed Web of Science ®Google Scholar
• Lyndrup J, Lamont RF. The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban. Expert Opin Investig Drugs 2007;16:843–53
   PubMed Web of Science ®Google Scholar
• King JF, Flenady VJ, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003;(1):CD002255
   Google Scholar
• Romero R, Sibai BM, Sanchez-Ramos L, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:1173–83
   PubMed Web of Science ®Google Scholar
• Carlin A, Norman J, Cole S, et al. Tocolytics and preterm labour. BMJ 2009;338:b195
   Google Scholar
• Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002–12
   PubMed Web of Science ®Google Scholar
• Smith GN, Guo Y, Wen SW, et al. Secondary analysis of the use of transdermal nitroglycerin for preterm labor. Am J Obstet Gynecol 2010;203:565–6
   PubMedGoogle Scholar
• Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database Syst Rev 2002;(3):CD002860
   Google Scholar
• Smith GN, Walker MC, Ohlsson A, et al. Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor. Am J Obstet Gynecol 2007;196:37–8
   PubMedGoogle Scholar
• Guo Y, Longo CJ, Xie R, et al. Cost-effectiveness of transdermal nitroglycerin use for preterm labor. Value Health 2011;14:240–6
   PubMedGoogle Scholar
• Kashanian M, Bahasadri S, Zolali B. Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor. Int J Gynaecol Obstet 2011;113:192–5
   PubMed Web of Science ®Google Scholar
• Savage AH, Anderson BL, Simhan HN. The safety of prolonged indomethacin therapy. Am J Perinatol 2007;24:207–13
   PubMed Web of Science ®Google Scholar
• Klauser CK, Briery CM, Keiser SD, et al. Effect of antenatal tocolysis on neonatal outcomes. J Matern Fetal Neonatal Med 2012;25:2778–81
   PubMed Web of Science ®Google Scholar
• Sandruck JC, Grobman WA, Gerber SE. The effect of short-term indomethacin therapy on amniotic fluid volume. Am J Obstet Gynecol 2005;192:1443–5
   PubMed Web of Science ®Google Scholar
• Loe SM, Sanchez-Ramos L, Kaunitz AM. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol 2005;106:173–9
   PubMed Web of Science ®Google Scholar
• Sood BG, Lulic-Botica M, Holzhausen KA, et al. The risk of necrotizing enterocolitis after indomethacin tocolysis. Pediatrics 2011;128:e54–62
   PubMed Web of Science ®Google Scholar
• Macones GA, Robinson CA. Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am J Obstet Gynecol 1997;177:819–24
   PubMed Web of Science ®Google Scholar
• Klam SL, Leduc L. Management options for preterm labour in Canada. J Obstet Gynaecol Can 2004;26:339–45
   PubMedGoogle Scholar
• Kofinas A, Kofinas J. Indomethacin as a diagnostic and therapeutic tool in the management of progressive cervical shortening diagnosed by trans-vaginal sonography. J Matern Fetal Neonatal Med 2011;24:79–85
   PubMed Web of Science ®Google Scholar
• Hayes E, Moroz L, Pizzi L, et al. A cost decision analysis of 4 tocolytic drugs. Am J Obstet Gynecol 2007;197:383–6
   PubMedGoogle Scholar
• Abramovici A, Cantu J, Jenkins SM. Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin North Am 2012;39:77–87
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Papageorghiou AT, Kennedy SH, et al. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG 2011;118:1042–54
   PubMed Web of Science ®Google Scholar
• de Heus R, Mulder EJ, Visser GH. Management of preterm labor: atosiban or nifedipine? Int J Womens Health 2010;2:137–42
   PubMedGoogle Scholar